Prostate Cancer & Men's Cancer News

Prostate Cancer & Men's Cancer News

Castrate-Resistant Pre-chemotherapy

• Provenge (Spicucel-T) immunotherapy
• A Phase 3 Randomized Trial Comparing TAK-700 Plus Prednisone with Placebo Plus Prednisone in Patients with Chemotherapy Naieve Metastatic Castration Resistant Prostate Cancer

Chemotherapy

• A PHASE 3 STUDY TO EVALUATE THE EFFICACY AND SAFETY OF DOCETAXEL AND PREDNISONE WITH OR WITHOUT LENALIDOMIDE IN SUBJECTS WITH CASTRATE-RESISTANT PROSTATE CANCER

Post Taxotere

• A Phase 3 Randomized Trial Comparing TAK-700 Plus Prednisone with Placebo Plus Prednisone in Patients with Metastatic Castration Resistant Prostate Cancer That Has Progressed During or Following Docetaxel Based Therapy
•  Provenge (Spicucel-T) immunotherapy

Heavily pretreated population

•  A Phase 1, First-in-Human Study Evaluating the Safety, Tolerability, and Pharmacokinetics of AMG 337 in Adult Subjects with Advanced Solid Tumors

Castrate-Resistant Pre-chemotherapy

• Provenge (Spicucel-T) immunotherapy
• A Phase 3 Randomized Trial Comparing TAK-700 Plus Prednisone with Placebo Plus Prednisone in Patients with Chemotherapy Naieve Metastatic Castration Resistant Prostate Cancer

Chemotherapy

• A PHASE 3 STUDY TO EVALUATE THE EFFICACY AND SAFETY OF DOCETAXEL AND PREDNISONE WITH OR WITHOUT LENALIDOMIDE IN SUBJECTS WITH CASTRATE-RESISTANT PROSTATE CANCER

Post Taxotere

• A Phase 3 Randomized Trial Comparing TAK-700 Plus Prednisone with Placebo Plus Prednisone in Patients with Metastatic Castration Resistant Prostate Cancer That Has Progressed During or Following Docetaxel Based Therapy
•  Provenge (Spicucel-T) immunotherapy

Heavily pretreated population

•  A Phase 1, First-in-Human Study Evaluating the Safety, Tolerability, and Pharmacokinetics of AMG 337 in Adult Subjects with Advanced Solid Tumors